drugset / Trial / NCT03509688
The Curative Effect of Entecavir Combined Resveratrol on HBV patients-a Multi-center, Random, Open Clinical Trial
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to use entecavir combined with other drug such as resveratrol and thymosin to treat patients with hepatitis B, which may provide a novel therapy target hepatitis B.
Timeline
- Start
- 2014-11
- Primary completion
- 2017-12
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Resveratrol | Small molecule | 1000 mg | — |
| Subject | Thymalfasin | Peptide | — | — |
| Background | Entecavir | Small molecule | 0.5 mg | — |